InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,300.80
(
0.45%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.42
(
1.12%
)
Bitcoin
61,579.85
(
1.26%
)
Post# of 438
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DanWebzster

Send PM Follow Ignore
Followers 10
Posts 1060
Boards Moderated 2
Alias Born 09/04/2000

DanWebzster

Member Level

Re: DanWebzster post# 322

Sunday, 08/26/2018 12:37:45 PM

Sunday, August 26, 2018 12:37:45 PM

Post# of 438
ICCC is a animal health biotech with potential for equity to double in value by 2020.

ICCC could gain FDA approval for its revolutionary Mastitis treatment by H1/20.

MAST OUT will not require milk discard as antibiotic treatments do. Milk discard cost an average of $82 per treated cow or about $200mn per year.

ICCC presently generates $11mn p.a. from its treatment for scours in newborn calves. The market for this product expected to grow

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up